Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 9

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 1
Chunk 9
---
Table of Contents             

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Condensed Consolidated Statements of Income (Unaudited)For the three months ended September 30For the nine months ended September 30(In millions, except per share amounts)2025202420252024Sales of products$3,375 $3,201 $9,755 $9,454 Sales of services1,769 1,662 5,172 4,899 Total revenues5,143 4,863 14,927 14,353 Cost of products2,270 2,033 6,392 6,045 Cost of services884 805 2,549 2,378 Gross profit1,990 2,026 5,987 5,930 Selling, general, and administrative1,045 1,034 3,114 3,139 Research and development292 316 937 967 Total operating expenses1,337 1,350 4,051 4,106 Operating income653 676 1,936 1,824 Interest and other financial charges – net111 130 335 383 Non-operating benefit (income) costs(75)(102)(222)(306)Other (income) expense – net(26)(9)(124)(1)Income before income taxes643 658 1,947 1,747 Benefit (provision) for income taxes(179)(168)(395)(435)Net income464 490 1,552 1,312 Net (income) loss attributable to noncontrolling interests(18)(19)(57)(40)Net income attributable to GE HealthCare$446 $470 $1,495 $1,272 Earnings per share attributable to GE HealthCare:Basic$0.98 $1.03 $3.27 $2.79 Diluted0.98 1.02 3.26 2.77 Weighted-average number of shares outstanding:Basic456457457456Diluted457459458459

The accompanying notes are an integral part of these condensed consolidated financial statements. 

4

Table of Contents             

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)For the three months ended September 30For the nine months ended September